The abuse potential of propofol

References

• Langley MS, Heel RC. Propofol. A review of its pharmacodynamic and pharmacokinetic properties and use as intravenous anaesthetic. Drugs 1998; 35:334–372.
   Google Scholar
• Bell DM, McDonough JP, Ellison JS, Fitzhugh EC. Controlled drug misuse by certified registered nurse anesthetists. AANA J 1999; 67:133–140.
   PubMedGoogle Scholar
• Roussin A, Montastruc JL, Lapeyre-Mestre M. Pharmacological and clinical evidences on the potential for abuse and dependence of propofol: a review of the literature. Fundam Clin Pharmacol 2007; 21:459–466.
   PubMed Web of Science ®Google Scholar
• Pain L, Gobaille S, Schleef C, Aunis D, Oberling P. In vivo dopamine measurements in the nucleus accumbens after nonanesthetic and anesthetic doses of propofol in rats. Anesth Analg 2002; 95:915–919.
   PubMed Web of Science ®Google Scholar
• Patel S, Wohlfeil ER, Rademacher DJ, Carrier EF, Perry LJ, Kundu A, Falck, JR, Nithipatikom K, Campbell WB, Hillard CJ. The general anesthetic propofol increases brain N-arachidonylethanolamine (anandamide) content and inhibits fatty acid amide hydrolase. Br J Pharmacol 2003; 139: 1005–1013.
   PubMed Web of Science ®Google Scholar
• Li K, Xiao C, Xiong M, Delphin E, Ye JH. Nanomolar propofol stimulates glutamate transmission to dopamine neurons: a possible mechanism of abuse potential. J Pharmacol Exp Ther 2008; 325:165–174.
   PubMed Web of Science ®Google Scholar
• Klausz G, Róna K, Kristóf I, Töro K. Evaluation of a fatal propofol intoxication due to self administration. J Forensic Leg Med 2009; 16:287–289.
   PubMedGoogle Scholar
• Iwersen-Bergmann S, Rösner P, Kühnau HC, Junge M, Schmoldt. Death after excessive propofol abuse. Int J Legal Med 2001; 114:248–251.
   PubMed Web of Science ®Google Scholar
• Weerts EM, Ator NA, Griffiths RR. Comparison of the intravenous reinforcing effects of propofol and methohexital in baboons. Drug Alcohol Depend 1999; 57:51–60.
   PubMed Web of Science ®Google Scholar
• LeSage MG, Stafford D, Glowa JR. Abuse liability of the anesthetic propofol: self-administration of propofol in rats under fixed-ratio schedules of drug delivery. Psychopharmacology 2000; 153:148–154.
   PubMed Web of Science ®Google Scholar
• Pain L, Oberling P, Sandner G, Di Scala G. Effect of propofol on affective state as assessed by place conditioning paradigm in rats. Anesthesiology 1996; 85:121–128.
   PubMed Web of Science ®Google Scholar
• Zacny JP, Lichtor JL, Coalson DW, Finn RS, Uitvlugt AM, Glosten B, Flemming DC, Apfelbaum JL. Subjective and psychomotor effects of subanesthetic doses of propofol in healthy volunteers. Anesthesiology 1992; 76:696–702.
   PubMed Web of Science ®Google Scholar
• Zacny JP, Lichtor L, Zaragoza JG, Coalson DW, Uitvlugt AM, Flemming DC, Binstock WB, Cutter T, Apfelbaum JL. Assessing the behavioral effects and abuse potential of propofol bolus injections in healthy volunteers. Drug Alcohol Depend 1993; 32:45–57.
   PubMed Web of Science ®Google Scholar
• Hunter DN, Thornily A, Whitburn R. Arousal from propofol. Anaesthesia 1987; 42:1128–1129.
   Web of Science ®Google Scholar
• Fritz GA, Niemczyk WE. Propofol dependency in a layperson. Anesthesiology 2002; 96:505–506.
   PubMed Web of Science ®Google Scholar
• Bradner B, Blagrove M, McCallum G, Bromley LM. Dreams, images and emotions associated with propofol anaesthesia. Anaesthesia 1997; 52:750–755.
   PubMed Web of Science ®Google Scholar
• Schneider U, Rada D, Rollnik JD, Passie T, Emrich HM. Propofol dependency after treatment of tension headache. Addict Biol 2001; 6:263–265.
   PubMed Web of Science ®Google Scholar
• Soyka M, Schutz, CG. Propofol dependency. Addiction 1997; 92:1369–1370.
   PubMed Web of Science ®Google Scholar
• Bonnet U, Harkener J, Scherbaum N. A case report of propofol dependence in a physician. J Psychoactive Drugs 2008; 40:215–217.
   PubMed Web of Science ®Google Scholar
• Carrasco G, Molina R, Costa, J, Soler JM, Cabre L. Propofol vs midazolam in short-, medium-, and long-term sedation of critically ill patients: a cost-benefit analysis. Chest 1993; 103:557–564.
   PubMed Web of Science ®Google Scholar
• Buckley PM. Propofol in patients needing long-term sedation in intensive care: an assessment of the development of tolerance: a pilot study. Intensive Care Med 1997; 23:969–974.
   PubMed Web of Science ®Google Scholar
• Deer TR, Rich GF. Propofol tolerance in a pediatric patient. Anesthesiology 1992; 77:828–829.
   PubMed Web of Science ®Google Scholar
• Setlock MA, Palmisano BW, Berens RJ, Rosner DR, Troshynski TJ, Murray KJ. Tolerance to propofol generally does not develop in pediatric patients undergoing radiation therapy. Anesthesiology 1996; 85:207–209.
   PubMed Web of Science ®Google Scholar
• Cohen Y, Feldinger E, Ogorek D, Weinbroum AA. Increased propofol requirement during succeeding administrations for electroconvulsive therapy. J Clin Anesth 2004; 16:282–285.
   PubMed Web of Science ®Google Scholar
• Fassoulaki A, Farinotti R, Mantz J, Desmonts JM. Does tolerance develop to the anaesthetic effects of propofol in rats? Br J Anaesth 1994; 72:127–128.
   PubMed Web of Science ®Google Scholar
• Ypsilantis P, Mikroulis D, Politou M, Tsoukali H, Pitiakoudis M, Didilis V, Theodorisidis G, Bougioukas G, Simopoulos C. Tolerance to propofol’s sedative effect in mechanically ventilated rabbits. Anesth Analg 2006; 103:359–360.
   PubMed Web of Science ®Google Scholar
• Miller LJ, Wiles-Pfeifler R. Propofol for the long-term sedation of a critically ill patient. Am J Crit Care 1998; 7:73–76.
   PubMedGoogle Scholar
• Boyle WA, Shear JM, White PF, Schuller D. Long-term sedative infusion in the intensive care unit: propofol vs midazolam. J Drug Dev 1991; 4(Suppl. 3):43–45.
   Google Scholar
• Cammarano WB, Pittet JF, Weitz S, Schlobohm RM, Marks JD. Acute withdrawal syndrome related to the administration of analgesic and sedative medications in adult intensive care unit patients. Crit Care Med 1998; 26:676–684.
   PubMed Web of Science ®Google Scholar
• Au J, Walker S, Scott DHT. Withdrawal syndrome after propofol infusion. Anaesthesia 1991; 46:238–239.
   Web of Science ®Google Scholar
• Valente JF, Anderson GL, Branson RD, Johnson DJ, Davis K Jr, Porembka DT. Disadvantages of prolonged propofol sedation in the critical care unit. Crit Care Med 1994; 22:710–712.
   PubMed Web of Science ®Google Scholar
• Grant IS, Worsley M. Withdrawal syndrome after propofol. Anaesthesia 1991; 46:238.
   PubMed Web of Science ®Google Scholar
• Follette JW, Farley WJ. Anesthesiologist addicted to propofol. Anesthesiology 1992; 77:817–818.
   PubMed Web of Science ®Google Scholar
• Odell M. Propofol abuse (letter). Anaesth Intensive Care 1999; 27:539.
   PubMed Web of Science ®Google Scholar
• Drummer, OH. A fatality due to propofol poisoning. J Forensic Sci 1992; 37:1186–1189.
   PubMed Web of Science ®Google Scholar
• Luck S, Hedrick J. The alarming trend of substance abuse in anesthesia providers. J Perianesth Nurs 2004; 19:308–311.
   PubMedGoogle Scholar
• Wischmeyer PE, Johnson BR, Wilson JE, Dingmann C, Bachman HM, Roller E, Tran ZV, Henthorn TK. A survey of propofol abuse in academic anesthesia programs. Anesth Analg 2007; 105:1066–1071.
   PubMed Web of Science ®Google Scholar
• Kranioti EF, Mavroforou A, Mylonakis P, Michalodimitrakis M. Lethal self administration of propofol (Diprivan). A case report and review of the literature. Forensic Sci Int 2007;167:56–58.
   PubMed Web of Science ®Google Scholar
• Kirby RR, Colaw JM, Douglas MM. Death from Propofol: Accident, Suicide, or Murder? Anesth Analg 2009; 108:1182–1184.
   PubMed Web of Science ®Google Scholar
• Riezzo I, Centini F, Neri M, Rossi G, Spanoudaki E, Turillazzi E, Fineschi V. Brugada-like EKG pattern and myocardial effects in a chronic propofol abuser. Clin Toxicol 2009; 47:358–363.
   PubMed Web of Science ®Google Scholar
• Weetman DB, Mascardo LA, Ross MB, Abramowitz PW. Propofol as a drug of diversion. Am J Health Syst Pharm 2004; 61:1185–1186.
   PubMed Web of Science ®Google Scholar
• Vernooy K, Delhaas T, Cremer OL, Di Diego JM, Oliva A, Timmermans C, Volders PG, Prinzen FW, Crijns HJ, Antzelevitch C, Kalkman CJ, Rodriguez LM, Brugada R. Electrocardiographic changes predicting sudden death in propofol-related infusion syndrome. Heart Rhythm 2006; 3:131–137.
   PubMed Web of Science ®Google Scholar
• Kumar AN, Schwartz DE, Lim KG. Propofol-induced pancreatitis. Chest 1999; 115:1198–1199.
   PubMed Web of Science ®Google Scholar
• Drug Enforcement Administration, Department of Justice. Schedules of controlled substances; placement of fospropofol into schedule IV Fed Regist 2009; 74(192):51234–51236.
   Google Scholar
• Hartle A, Malhotra S. The safety of propofol. BMJ 2009; 339:928.
   Google Scholar